NCT03800199

Brief Summary

The aim of the investigator's study is to determine the validity and reliability of the Turkish version of the Combined Index of Severity (ICAF) in Turkish patients with Fibromyalgia Syndrome (FMS).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 7, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 11, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

April 13, 2019

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

August 16, 2022

Status Verified

August 1, 2022

Enrollment Period

5.1 years

First QC Date

January 7, 2019

Last Update Submit

August 15, 2022

Conditions

Keywords

health statuesobservational studyquestionnaire

Outcome Measures

Primary Outcomes (1)

  • Combined Index of Severity of Fibromyalgia

    Composed of 59 items, measures the combined severity index of fibromyalgia divided into 4 factors: physical, emotional, social and active and passive coping.The ICAF score ranges from 0 to 84, with higher values indicating higher severity.

    Changes from baseline severity at 12 weeks.

Other Outcomes (7)

  • Revised-Fibromyalgia Impact Questionnaire (FIQR)

    Changes from baseline at 12 weeks.

  • Socio-demographic and clinical characteristics

    Changes from baseline at 12 weeks.

  • Body Mass Index (BMI)

    Changes from baseline at 12 weeks.

  • +4 more other outcomes

Study Arms (1)

Perceptive Rehabilitation (PR-group)

EXPERIMENTAL

Perceptive rehabilitation group will receive a treatment that, as described by on Paolucci et al. (2015). This treatment will include small latex cones with different resistance. In each session there will be over 100 cones will be placed on a rigid wood with using elastic strips. The patient will be asked to lie down supine on the material. Patients weigh will create pressure and reaction force to his/her body. Treatments will be 2 times a week till 8 weeks. There will be in total 16 sessions.

Other: Perceptive rehabilitation

Interventions

The first session will be an education session. Spinous processes will be reference line of the body and patient will lie down on cones. The therapist will ask the patient first to breathe normally and feel the pressure. This will lead the patient to relax and understand cones. Then, the patient will start with the diagrammatic breathing. After breath exercises patient will perform active exercises (include stretching, warming up and cooling down) on supervision. Exercises will include the whole body. Additional to this during the session therapist will ask about the pressure of cones and she will correct the patients' posture. At the end of all the session, the therapist will take a photo of the patients back with the aim of to document the pressure and hyperaemic areas.

Perceptive Rehabilitation (PR-group)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Having a Fibromyalgia diagnosis according to Wolfe et al. (2016) criteria.
  • Feeling Fibromyalgia symptoms last 3 mounts

You may not qualify if:

  • Having physical and functional problems with FMS
  • Having a diagnosis of chronic pain other than FMS,
  • Using medicine other than simple analgesics,
  • History of cardiovascular or pulmonary diseases
  • Can not read and write in Turkish language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eastern Mediterranean University

Famagusta, Cyprus

RECRUITING

Related Publications (1)

  • Paolucci T, Baldari C, Di Franco M, Didona D, Reis V, Vetrano M, Iosa M, Trifoglio D, Zangrando F, Spadini E, Saraceni VM, Guidetti L. A New Rehabilitation Tool in Fibromyalgia: The Effects of Perceptive Rehabilitation on Pain and Function in a Clinical Randomized Controlled Trial. Evid Based Complement Alternat Med. 2016;2016:7574589. doi: 10.1155/2016/7574589. Epub 2016 Jan 13.

    PMID: 26884794BACKGROUND

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Beraat Alptug, MSc

    European University of Lefke

    PRINCIPAL INVESTIGATOR
  • Emine H. Tüzün, Prof. Dr.

    Eastern Mediterranean University

    PRINCIPAL INVESTIGATOR
  • Levent Eker, M. D.

    Eastern Mediterranean University

    PRINCIPAL INVESTIGATOR
  • Gülbin Ergin, PhD

    European University of Lefke

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Beraat Alptug, MSc

CONTACT

Emine H. Tüzün, Prof. Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Questionnaire: Combined Index of Severity of Fibromyalgia (ICAF) Intervention: Perceptive rehabilitation Procedure: Assessment of reliability, acceptability, validity and responsiveness.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master Physiotherapist/ Principal Investigator

Study Record Dates

First Submitted

January 7, 2019

First Posted

January 11, 2019

Study Start

April 13, 2019

Primary Completion

June 1, 2024

Study Completion

July 1, 2024

Last Updated

August 16, 2022

Record last verified: 2022-08

Locations